Diabetes Technology Meeting – October 15-17, 2024

Join the 24th Annual Diabetes Technology Meeting in Burlingame, California

Explore groundbreaking advancements in diabetes care at the Diabetes Technology Meeting 2024, held in Burlingame, California, from October 15-17, 2024. This premier event is designed for healthcare professionals, researchers, and technology developers, providing insight into the latest technologies and practices in diabetes management.

Event Overview

The Diabetes Technology Meeting is an ideal platform to gain in-depth knowledge about recent innovations in diabetes technology. The event will cover: 

Artificial Intelligence in Diabetes Care

Learn about the role of AI in improving diabetes data analysis, diagnosis, and patient outcomes.  

Continuous Glucose Monitors (CGMs)

Discover the latest research on how CGMs are being used beyond blood glucose monitoring, including nutrition tracking for prediabetes and use by elite athletes.  

Data Security in Diabetes Devices

Discussions will address patient data security, including HIPAA and FTC considerations.  

Economics of Digital Health Interventions

Learn about the evidence needed by payers to support the use of diabetes devices and the impact of digital health tools on improving the patient experience.

Session Highlights

Day 1 will kick off with Workshop A: Data Science and Artificial Intelligence, moderated by Shahid Shah. This session features a lineup of esteemed speakers, including Mark Clements, MD PhD CPI FAAP from CHILDREN’S MERCY HOSPITAL KANSAS, who will discuss the transformative potential of the Rising T1DE Alliance and the D-Data to transform care via the integration of CGM and other clinical data. Ali Cinar from the Illinois Institute of Technology will share insights on AI technologies that enhance diabetes treatment, amongst other sessions.

Following a break, Workshop A, Session 2: Real World Evidence for Diabetes Trials will take center stage, moderated by Sun Kim from Stanford University. This session will delve into the application of real-world data in diabetes care, including a presentation on harnessing the University of California, San Francisco’s health data warehouse to learn effective and safe treatments in Type 2 Diabetes, presented by Rohit Vashisht.

In the afternoon, Workshop B, Session 1: New Diagnostic Tests will highlight advancements in diabetes diagnostics, moderated by Dr. George A. Brooks from University of California, Berkeley and Koji Sode from University of North Carolina at Chapel Hill. The session will include presentations from Aaron Kowalski from Breakthrough T1D on current research programs and Zoe Quandt from University of California, San Francisco, who will discuss the role of antibodies in diagnosing diabetes.

Finally, Workshop B, Session 2: Drugs, Insulin, and Technology will be moderated by Guillermo Arreaza -Rubín from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and The National Institutes of Health. The session will include key presentations, including Alexander Fleming’s on solutions for age-related and drug-induced muscle loss. Day 1 will conclude with a Q&A session and poster presentations.

Workshops and Research Programs

The meeting will feature multiple workshops: 

  • Drugs, Insulin, and Technology: This session will discuss the latest developments in diabetes medications and insulin storage solutions.
  • GLP-1 Receptor Agonists: Learn about the use of GLP-1 receptor agonists before surgery and how they are integrated with advanced insulin delivery systems. 

A poster session will also be held to showcase the most promising current research programs and clinical trials in diabetes technology.

Startup Showcase & Innovation Challenge

The Startup Showcase will feature innovative startups presenting their groundbreaking solutions in diabetes technology. Additionally, the Innovation Challenge will allow participants to pitch their ideas, providing valuable feedback from industry leaders. The showcase and challenge are great opportunities for networking and gaining visibility in the field.

Venue & Travel Information

The Diabetes Technology Meeting 2024 will be held at the Hyatt Regency San Francisco Airport (1333 Bayshore Highway, Burlingame, CA 94010), offering a comfortable and convenient location for all participants. Located just minutes away from San Francisco International Airport, the venue provides easy access and a range of amenities to make your stay enjoyable. 

Key Takeaways for Attendees

Accommodation Tips:

Why Attend?

The Diabetes Technology Meeting is the leading event for diabetes technology professionals. From new product showcases to interactive sessions, you’ll leave with a wealth of knowledge to improve diabetes care practices. Whether you’re a researcher, healthcare provider, or technology enthusiast, this is your chance to be at the forefront of diabetes innovation. 

Frequently Asked Questions

Who should attend the Diabetes Technology Meeting?

The event is ideal for healthcare professionals, researchers, medical device developers, and anyone involved in diabetes care. 

The meeting will cover topics like glucose monitoring, insulin delivery, FDA diabetes regulation, and other emerging technologies.

Click the Register Now button to sign up for the Diabetes Technology Meeting 2024.

Orange Biomed Startup Showcase and Abstract Presentation

Join Orange Biomed at the Diabetes Technology Meeting 2024

At the Diabetes Technology Meeting (DTM), Orange Biomed will spotlight the urgent need to address A1C testing gaps in non-white populations. As part of the Startup Showcase and poster presentations, Orange Biomed will introduce the world’s first microfluidic-based A1C test—a groundbreaking innovation anticipated to receive FDA Clearance in 2025.

Key Focus: Reducing Disparities in A1C Testing

  • Understanding the Gaps: Discuss the current challenges in A1C testing that disproportionately affect non-white populations.
  • Innovative Solutions: Learn about the OBM rapid A1c test, a portable, quick, and reliable A1C test that offers lab-level accuracy without recalibration or refrigeration.

Join Our Sessions:

  • Poster Presentation (Tuesday, October 15, 4:30-6:30pm): Dr. Eunyoung Park from Orange Biomed will present on the impact of hemoglobin variants on A1C accuracy and how OBM rapid A1c bridges this gap. The presentation abstract is entitled “Implementing a stiffness measurement of red blood cells to predict HbA1c” (slot #27).
  • Startup Showcase (Wednesday, October 16, 5-7pm): Orange Biomed will present the OBM rapid A1c solution, demonstrating how new testing approaches can revolutionize diabetes management and foster equity.

Orange Biomed's Role at DTM

Speaking Engagements:

  • Future Panel Discussions: Representatives from Orange Biomed will be available for Q&A and arranging future panel discussions about the impact of A1C inaccuracies and the new technology’s capabilities.

Engaging with Attendees:

  • Visit our booth for live demos, and learn about the technology directly from our experts.
  • Schedule a Meeting: Use the form on this landing page to book a 1-1 meeting with Orange Biomed leadership.

Booth & Presentation Details:

  • Poster Presentation (slot #27) on Tuesday, October 15, 4:30-6:30pm.
    1. Background: Hemoglobin Glycation and RBC Stiffness
    2. Problem: Limitations of Current A1c Testing Methods
    3. Materials and Methods: Microfluidic Sensor, Blood samples
    4. Results and Discussion: RBCs velocity and level of HbA1c, A new algorithm for HbA1c measurement based on RBC stiffness, Stable data acquisition not affected by sampling volume
  • Startup Showcase on Wednesday, October 16, 5-7pm.
    • Product Featured: OBM rapid A1c, a next-gen A1C test designed for equitable diabetes management, using microfluidic technology for lab-level accuracy in just 5 minutes.

Addressing the Need for Equity in Diabetes Care

OBM rapid A1c provides an accurate, convenient way to test A1C, with a focus on addressing inaccuracies often found among non-white populations due to hemoglobin variants. With FDA clearance expected in 2025, Orange Biomed aims to bring this technology to healthcare providers and patients, ensuring equitable access to reliable diabetes management tools.

Why Attend Our Presentation?

Collaborate with Us

We are actively seeking collaborations with healthcare providers, researchers, and technology innovators. If you’re interested in partnering with us or want to set up a meeting during the Diabetes Technology Meeting, please reach out via the form on this landing page.

Preview OBM rapid A1c

Register Now to see Orange Biomed’s presentation and explore how our technology can revolutionize A1C testing. Book a Meeting to connect with our experts during the Diabetes Technology Meeting or to set up a virtual 1-1 meeting before or after the conference

Join Us

Please leave us a message, and we will get in touch shortly.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Make your First Step

Careers

If you are looking for a career opportunity, email us at

Collaboration

If you are interested in a collaboration opportunity, email us at